We are live on ! Find out more
GNTA

Genenta Science

5 hedge funds and large institutions have $2.1M invested in Genenta Science in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

48% more capital invested

Capital invested by funds: $1.42M → $2.1M (+$680K)

25% more funds holding

Funds holding: 45 (+1)

0.97% more ownership

Funds ownership: 1.97%2.95% (+0.97%)

Holders
5
Holders Change
+1
Holders Change %
+25%
% of All Funds
0.07%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
2
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$46.5K
Name Holding Trade Value Shares
Change
Change in
Stake
A
1
Allianz
Germany
$927K +$524K +130,300 +126%
AG
2
AlTi Global
New York
$795K
AU
3
Algebris (UK)
United Kingdom
$368K +$221K +55,000 +122%
Morgan Stanley
4
Morgan Stanley
New York
$13.5K +$13.7K +3,400 New
UBS Group
5
UBS Group
Switzerland
$361 +$366 +91 New
Citadel Advisors
6
Citadel Advisors
Florida
-$46.5K -11,167 Closed

GNTA Hedge Fund Activity: Q1 2025 in Review

5 of the 7,461 institutional investors tracked by Wall St. Rank reported a position in Genenta Science (GNTA) for Q1 2025, worth a combined $2.1M — up 48% from $1.42M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new GNTA positions and 1 closed out — a net gain of 1 holder — while 2 added to existing stakes and 0 trimmed.

The largest buyer was Allianz, adding an estimated $524K. The largest seller was Citadel Advisors, exiting entirely with an estimated $46.5K sold.

  • 5 institutional investors held Genenta Science (GNTA) as of Q1 2025, up from 4 in Q4 2024.
  • Funds reported $2.1M of Genenta Science stock for Q1 2025, up 48% quarter-over-quarter.
  • 2 funds opened new Genenta Science positions in Q1 2025 and 1 closed out, a net change of +1 holder.
  • The largest Genenta Science buyer in Q1 2025 was Allianz, an estimated $524K added.
  • The largest Genenta Science seller in Q1 2025 was Citadel Advisors, an estimated $46.5K sold.

Based on aggregated 13F filings for Q1 2025.